| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Progesterone | 47 | 2013 | 866 | 3.600 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 18 | 2020 | 33 | 3.470 |
Why?
|
| Lactoferrin | 19 | 2008 | 77 | 2.560 |
Why?
|
| Progesterone | 31 | 2013 | 624 | 1.980 |
Why?
|
| Receptors, Steroid | 23 | 2018 | 269 | 1.890 |
Why?
|
| Receptors, Thyroid Hormone | 12 | 2018 | 84 | 1.750 |
Why?
|
| DNA-Binding Proteins | 25 | 2018 | 2055 | 1.690 |
Why?
|
| Mammary Glands, Animal | 22 | 2018 | 482 | 1.570 |
Why?
|
| Nerve Tissue Proteins | 15 | 2018 | 1112 | 1.550 |
Why?
|
| Leukemia, Myeloid, Acute | 5 | 2020 | 533 | 1.290 |
Why?
|
| Reproduction | 7 | 2003 | 243 | 1.000 |
Why?
|
| Uterus | 15 | 2006 | 594 | 0.920 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2020 | 1872 | 0.820 |
Why?
|
| Transcription Factors | 20 | 2020 | 2587 | 0.810 |
Why?
|
| Dihydroergotamine | 2 | 2020 | 10 | 0.790 |
Why?
|
| Mice, Knockout | 35 | 2018 | 3722 | 0.790 |
Why?
|
| Mammary Glands, Human | 4 | 2007 | 79 | 0.780 |
Why?
|
| Animals | 102 | 2020 | 33798 | 0.770 |
Why?
|
| Cell Proliferation | 8 | 2020 | 2307 | 0.760 |
Why?
|
| Mammary Neoplasms, Experimental | 7 | 2018 | 244 | 0.750 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2020 | 298 | 0.730 |
Why?
|
| Mice | 62 | 2020 | 17542 | 0.710 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 11 | 2007 | 383 | 0.690 |
Why?
|
| Signal Transduction | 15 | 2020 | 4494 | 0.690 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2020 | 186 | 0.620 |
Why?
|
| Epigenesis, Genetic | 3 | 2020 | 664 | 0.600 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2018 | 49 | 0.590 |
Why?
|
| Vasoconstrictor Agents | 1 | 2018 | 137 | 0.570 |
Why?
|
| Gene Expression Regulation | 19 | 2016 | 2524 | 0.560 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2018 | 617 | 0.560 |
Why?
|
| Transcriptome | 3 | 2018 | 903 | 0.560 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 182 | 0.560 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2018 | 533 | 0.550 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2018 | 718 | 0.540 |
Why?
|
| Tamoxifen | 2 | 2018 | 363 | 0.540 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2016 | 9 | 0.530 |
Why?
|
| Morphogenesis | 3 | 2013 | 211 | 0.530 |
Why?
|
| Dopamine | 13 | 2003 | 284 | 0.520 |
Why?
|
| Transcription, Genetic | 18 | 2018 | 1702 | 0.470 |
Why?
|
| Receptors, Estrogen | 13 | 2018 | 791 | 0.460 |
Why?
|
| Ovary | 9 | 2006 | 389 | 0.430 |
Why?
|
| Breast Neoplasms | 7 | 2018 | 2479 | 0.420 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 14 | 2010 | 33 | 0.410 |
Why?
|
| Mice, Inbred C57BL | 17 | 2015 | 4357 | 0.400 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2020 | 886 | 0.380 |
Why?
|
| Sexual Behavior, Animal | 6 | 2006 | 87 | 0.380 |
Why?
|
| Ovulation | 4 | 2010 | 113 | 0.380 |
Why?
|
| Estradiol | 10 | 2013 | 536 | 0.370 |
Why?
|
| Estrogens | 11 | 2001 | 508 | 0.370 |
Why?
|
| Cell Movement | 4 | 2008 | 831 | 0.360 |
Why?
|
| Epithelium | 9 | 2013 | 362 | 0.350 |
Why?
|
| Mammary Neoplasms, Animal | 4 | 2007 | 137 | 0.350 |
Why?
|
| Myeloproliferative Disorders | 1 | 2011 | 90 | 0.330 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2011 | 137 | 0.330 |
Why?
|
| Gene Dosage | 1 | 2011 | 440 | 0.320 |
Why?
|
| Protein Isoforms | 7 | 2003 | 408 | 0.310 |
Why?
|
| DNA | 19 | 2003 | 1588 | 0.310 |
Why?
|
| RNA, Messenger | 17 | 2016 | 2809 | 0.310 |
Why?
|
| Mice, Inbred BALB C | 8 | 2018 | 1003 | 0.300 |
Why?
|
| Embryonic and Fetal Development | 2 | 1999 | 132 | 0.300 |
Why?
|
| Respiratory Burst | 1 | 2008 | 10 | 0.300 |
Why?
|
| Base Sequence | 22 | 2012 | 3091 | 0.300 |
Why?
|
| Neutrophils | 3 | 2008 | 373 | 0.290 |
Why?
|
| Mesencephalon | 4 | 2003 | 42 | 0.290 |
Why?
|
| Breast | 4 | 2007 | 214 | 0.290 |
Why?
|
| Iron | 6 | 2003 | 262 | 0.280 |
Why?
|
| Recombinant Proteins | 10 | 1998 | 1386 | 0.280 |
Why?
|
| Leukemia, Myeloid | 1 | 2007 | 85 | 0.280 |
Why?
|
| Female | 53 | 2018 | 65562 | 0.280 |
Why?
|
| Cloning, Molecular | 15 | 1997 | 892 | 0.280 |
Why?
|
| Progestins | 1 | 2007 | 48 | 0.270 |
Why?
|
| Recombinant Fusion Proteins | 7 | 2001 | 767 | 0.270 |
Why?
|
| Gene Expression | 9 | 2009 | 1565 | 0.260 |
Why?
|
| Cell Division | 12 | 2009 | 780 | 0.260 |
Why?
|
| Molecular Sequence Data | 20 | 2006 | 3867 | 0.250 |
Why?
|
| Cell Survival | 3 | 2009 | 808 | 0.250 |
Why?
|
| Genitalia, Female | 2 | 2005 | 47 | 0.240 |
Why?
|
| Humans | 53 | 2020 | 123180 | 0.240 |
Why?
|
| Immunity, Mucosal | 2 | 2002 | 83 | 0.240 |
Why?
|
| Apoptosis | 7 | 2018 | 1782 | 0.230 |
Why?
|
| Plasmids | 8 | 2016 | 511 | 0.230 |
Why?
|
| Chickens | 19 | 1993 | 636 | 0.220 |
Why?
|
| Pyramidal Cells | 1 | 2004 | 167 | 0.210 |
Why?
|
| Blotting, Western | 10 | 2014 | 1100 | 0.210 |
Why?
|
| DNA Damage | 4 | 2018 | 512 | 0.210 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2002 | 280 | 0.200 |
Why?
|
| Protein Binding | 8 | 2016 | 1741 | 0.200 |
Why?
|
| Cells, Cultured | 9 | 2018 | 3040 | 0.200 |
Why?
|
| Semicircular Canals | 1 | 2002 | 21 | 0.200 |
Why?
|
| Embryo Implantation | 2 | 2002 | 230 | 0.200 |
Why?
|
| Tumor Cells, Cultured | 5 | 2018 | 1061 | 0.190 |
Why?
|
| Promoter Regions, Genetic | 12 | 2009 | 1339 | 0.190 |
Why?
|
| Dermatitis | 1 | 2001 | 25 | 0.190 |
Why?
|
| Axons | 1 | 2004 | 380 | 0.190 |
Why?
|
| Genes | 7 | 1992 | 444 | 0.180 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 2001 | 58 | 0.180 |
Why?
|
| Cell Cycle Proteins | 2 | 2020 | 643 | 0.180 |
Why?
|
| Oncogenes | 2 | 2020 | 168 | 0.180 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2015 | 996 | 0.170 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2020 | 53 | 0.170 |
Why?
|
| Neurons | 6 | 2003 | 1938 | 0.160 |
Why?
|
| Pregnancy | 13 | 2004 | 7146 | 0.160 |
Why?
|
| Seizures | 1 | 2004 | 874 | 0.160 |
Why?
|
| Immunity, Innate | 1 | 2002 | 372 | 0.160 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2016 | 510 | 0.160 |
Why?
|
| Hippocampus | 1 | 2004 | 819 | 0.160 |
Why?
|
| Cellular Reprogramming | 1 | 2020 | 115 | 0.150 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2018 | 17 | 0.150 |
Why?
|
| Luteinizing Hormone | 3 | 2010 | 120 | 0.150 |
Why?
|
| Gastrointestinal Diseases | 1 | 2001 | 334 | 0.150 |
Why?
|
| Amino Acid Sequence | 12 | 1997 | 2695 | 0.150 |
Why?
|
| Membrane Transport Proteins | 2 | 2012 | 175 | 0.140 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 285 | 0.140 |
Why?
|
| Intestinal Mucosa | 1 | 2003 | 771 | 0.140 |
Why?
|
| Inflammation | 3 | 2018 | 1403 | 0.140 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2009 | 239 | 0.140 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2016 | 239 | 0.140 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2018 | 202 | 0.140 |
Why?
|
| Mice, SCID | 1 | 2018 | 570 | 0.140 |
Why?
|
| Lymph Nodes | 2 | 2000 | 376 | 0.140 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 1997 | 65 | 0.140 |
Why?
|
| Mice, Nude | 1 | 2018 | 694 | 0.130 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 254 | 0.130 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 2016 | 14 | 0.130 |
Why?
|
| Binding Sites | 8 | 1997 | 1292 | 0.130 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2016 | 44 | 0.130 |
Why?
|
| Pro-Opiomelanocortin | 1 | 1997 | 94 | 0.130 |
Why?
|
| Ovariectomy | 6 | 2006 | 182 | 0.130 |
Why?
|
| Amino Acid Motifs | 1 | 2016 | 199 | 0.130 |
Why?
|
| Atherosclerosis | 3 | 2013 | 833 | 0.120 |
Why?
|
| Dendritic Cells | 1 | 1998 | 403 | 0.120 |
Why?
|
| Posture | 5 | 2006 | 152 | 0.120 |
Why?
|
| Disease Susceptibility | 2 | 2008 | 297 | 0.120 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2015 | 97 | 0.110 |
Why?
|
| Central Nervous System | 1 | 1996 | 253 | 0.110 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 3291 | 0.110 |
Why?
|
| Cell Lineage | 1 | 2016 | 340 | 0.110 |
Why?
|
| Ligands | 7 | 2006 | 533 | 0.110 |
Why?
|
| Chromosome Mapping | 3 | 2016 | 1082 | 0.110 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 664 | 0.110 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2013 | 25 | 0.110 |
Why?
|
| Cytoplasmic Granules | 1 | 2014 | 47 | 0.110 |
Why?
|
| Mast Cells | 1 | 2014 | 74 | 0.110 |
Why?
|
| Mice, 129 Strain | 1 | 2013 | 98 | 0.110 |
Why?
|
| Immunohistochemistry | 7 | 2006 | 1688 | 0.110 |
Why?
|
| Mice, Inbred ICR | 3 | 1999 | 147 | 0.110 |
Why?
|
| Early Growth Response Protein 1 | 2 | 2011 | 38 | 0.110 |
Why?
|
| Saccharomyces cerevisiae | 3 | 1993 | 424 | 0.110 |
Why?
|
| Stem Cells | 1 | 1998 | 701 | 0.110 |
Why?
|
| Aspergillus oryzae | 1 | 1992 | 8 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 1012 | 0.100 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2012 | 74 | 0.100 |
Why?
|
| Oxidative Stress | 1 | 2018 | 795 | 0.100 |
Why?
|
| Benzamides | 1 | 2012 | 106 | 0.100 |
Why?
|
| Phenotype | 4 | 2011 | 4226 | 0.100 |
Why?
|
| Histones | 1 | 2016 | 527 | 0.100 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 1992 | 54 | 0.100 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 3 | 2006 | 110 | 0.100 |
Why?
|
| Gene Silencing | 1 | 2012 | 236 | 0.100 |
Why?
|
| Thymus Gland | 2 | 2003 | 100 | 0.100 |
Why?
|
| Pyridines | 1 | 2012 | 224 | 0.090 |
Why?
|
| Epithelial Cells | 5 | 2007 | 899 | 0.090 |
Why?
|
| Computational Biology | 1 | 2016 | 804 | 0.090 |
Why?
|
| Organ Specificity | 5 | 2006 | 423 | 0.090 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2011 | 15 | 0.090 |
Why?
|
| Cell Compartmentation | 1 | 2011 | 42 | 0.090 |
Why?
|
| Pregnancy, Animal | 2 | 2001 | 75 | 0.090 |
Why?
|
| Receptors, Cell Surface | 1 | 1992 | 469 | 0.090 |
Why?
|
| Cumulus Cells | 1 | 2010 | 43 | 0.080 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2010 | 31 | 0.080 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 1989 | 20 | 0.080 |
Why?
|
| Paracrine Communication | 1 | 2010 | 71 | 0.080 |
Why?
|
| Genes, p53 | 2 | 2007 | 213 | 0.080 |
Why?
|
| Mice, Inbred Strains | 4 | 2003 | 311 | 0.080 |
Why?
|
| Transfection | 10 | 2006 | 1068 | 0.080 |
Why?
|
| Protein Kinases | 1 | 2011 | 330 | 0.080 |
Why?
|
| Ovarian Follicle | 1 | 2010 | 119 | 0.080 |
Why?
|
| Macrophages | 1 | 2013 | 605 | 0.080 |
Why?
|
| Transferrin | 2 | 2003 | 51 | 0.080 |
Why?
|
| In Situ Hybridization | 3 | 2003 | 473 | 0.080 |
Why?
|
| Mice, Mutant Strains | 5 | 2009 | 382 | 0.080 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 936 | 0.080 |
Why?
|
| Blotting, Southern | 3 | 1992 | 215 | 0.080 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2002 | 253 | 0.080 |
Why?
|
| Mifepristone | 2 | 2006 | 138 | 0.080 |
Why?
|
| Secretory Vesicles | 1 | 2008 | 20 | 0.080 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2008 | 68 | 0.080 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2008 | 105 | 0.070 |
Why?
|
| Monocytes | 1 | 2010 | 345 | 0.070 |
Why?
|
| Chloroquine | 1 | 2007 | 32 | 0.070 |
Why?
|
| Peroxidase | 1 | 2008 | 60 | 0.070 |
Why?
|
| Aspergillus | 3 | 1997 | 27 | 0.070 |
Why?
|
| Hypothalamus | 3 | 2006 | 216 | 0.070 |
Why?
|
| Cell Differentiation | 3 | 2008 | 1909 | 0.070 |
Why?
|
| Benzazepines | 2 | 2006 | 64 | 0.070 |
Why?
|
| Corpus Striatum | 2 | 2005 | 89 | 0.070 |
Why?
|
| Blast Crisis | 1 | 2007 | 17 | 0.070 |
Why?
|
| NADPH Oxidases | 1 | 2008 | 114 | 0.070 |
Why?
|
| Structure-Activity Relationship | 4 | 2005 | 567 | 0.070 |
Why?
|
| Phagocytosis | 1 | 2008 | 169 | 0.070 |
Why?
|
| Substance-Related Disorders | 1 | 1992 | 458 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 2 | 1996 | 2396 | 0.070 |
Why?
|
| Rats, Inbred WF | 6 | 2002 | 21 | 0.070 |
Why?
|
| Multigene Family | 4 | 1997 | 298 | 0.070 |
Why?
|
| Leukocytes | 1 | 2008 | 206 | 0.070 |
Why?
|
| Models, Biological | 5 | 2003 | 1442 | 0.070 |
Why?
|
| Estrous Cycle | 1 | 2006 | 33 | 0.070 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2006 | 42 | 0.070 |
Why?
|
| Consensus Sequence | 2 | 1997 | 59 | 0.070 |
Why?
|
| Glycosylation | 2 | 1997 | 114 | 0.070 |
Why?
|
| Disease Progression | 2 | 2011 | 2028 | 0.070 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2008 | 166 | 0.070 |
Why?
|
| Protein Biosynthesis | 3 | 1989 | 664 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2014 | 1290 | 0.070 |
Why?
|
| Sequence Homology, Nucleic Acid | 4 | 1992 | 287 | 0.070 |
Why?
|
| Rats | 8 | 2009 | 3651 | 0.070 |
Why?
|
| NF-kappa B | 2 | 2014 | 457 | 0.070 |
Why?
|
| Mucins | 1 | 2006 | 74 | 0.070 |
Why?
|
| Alleles | 1 | 2011 | 1603 | 0.060 |
Why?
|
| Cell Line | 9 | 1998 | 2771 | 0.060 |
Why?
|
| Dopamine Agonists | 1 | 2006 | 79 | 0.060 |
Why?
|
| Tissue Distribution | 3 | 2006 | 382 | 0.060 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2006 | 160 | 0.060 |
Why?
|
| Synovial Membrane | 2 | 2002 | 27 | 0.060 |
Why?
|
| Wound Healing | 1 | 2009 | 451 | 0.060 |
Why?
|
| Neurotransmitter Agents | 2 | 2003 | 145 | 0.060 |
Why?
|
| DNA Primers | 4 | 2012 | 660 | 0.060 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2004 | 18 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2007 | 467 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2007 | 697 | 0.060 |
Why?
|
| Kainic Acid | 1 | 2004 | 26 | 0.060 |
Why?
|
| Blotting, Northern | 5 | 2001 | 258 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2002 | 665 | 0.060 |
Why?
|
| Transcriptional Activation | 4 | 2006 | 482 | 0.060 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1996 | 135 | 0.060 |
Why?
|
| Staphylococcus aureus | 1 | 2008 | 455 | 0.060 |
Why?
|
| Membrane Glycoproteins | 2 | 2003 | 411 | 0.060 |
Why?
|
| Introns | 2 | 1997 | 301 | 0.060 |
Why?
|
| Heat-Shock Proteins | 3 | 1991 | 194 | 0.060 |
Why?
|
| Acute Disease | 1 | 2007 | 1093 | 0.060 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2003 | 14 | 0.050 |
Why?
|
| Antigens, Neoplasm | 1 | 2006 | 385 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 1660 | 0.050 |
Why?
|
| Cyclins | 2 | 2009 | 101 | 0.050 |
Why?
|
| Gene Deletion | 2 | 2015 | 792 | 0.050 |
Why?
|
| RANK Ligand | 1 | 2003 | 49 | 0.050 |
Why?
|
| Animals, Suckling | 1 | 2003 | 50 | 0.050 |
Why?
|
| Flow Cytometry | 3 | 2013 | 803 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 2 | 1997 | 782 | 0.050 |
Why?
|
| Neuropeptides | 1 | 2003 | 114 | 0.050 |
Why?
|
| Mutation | 5 | 2015 | 5767 | 0.050 |
Why?
|
| Animals, Newborn | 2 | 2003 | 992 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2005 | 440 | 0.050 |
Why?
|
| Cytokines | 2 | 2014 | 1284 | 0.050 |
Why?
|
| Exons | 2 | 1997 | 794 | 0.050 |
Why?
|
| Duodenum | 1 | 2003 | 97 | 0.050 |
Why?
|
| Milk | 1 | 2003 | 118 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 2005 | 1017 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 330 | 0.050 |
Why?
|
| Host-Parasite Interactions | 1 | 2002 | 68 | 0.050 |
Why?
|
| Adenoviridae | 3 | 2002 | 608 | 0.050 |
Why?
|
| Methylnitrosourea | 4 | 2002 | 19 | 0.050 |
Why?
|
| Carotid Artery Injuries | 1 | 2001 | 39 | 0.050 |
Why?
|
| Colforsin | 2 | 2001 | 48 | 0.050 |
Why?
|
| Male | 14 | 2015 | 60173 | 0.050 |
Why?
|
| Safety | 1 | 2001 | 218 | 0.040 |
Why?
|
| Postural Balance | 1 | 2002 | 125 | 0.040 |
Why?
|
| Ligases | 1 | 2000 | 46 | 0.040 |
Why?
|
| Crosses, Genetic | 1 | 2000 | 162 | 0.040 |
Why?
|
| Gene Targeting | 2 | 1998 | 178 | 0.040 |
Why?
|
| Langerhans Cells | 1 | 2000 | 21 | 0.040 |
Why?
|
| Lung | 1 | 2008 | 1466 | 0.040 |
Why?
|
| Epidermis | 1 | 2000 | 60 | 0.040 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 1999 | 6 | 0.040 |
Why?
|
| Fertility | 2 | 1999 | 263 | 0.040 |
Why?
|
| Models, Animal | 1 | 2002 | 464 | 0.040 |
Why?
|
| Hypersensitivity | 1 | 2002 | 182 | 0.040 |
Why?
|
| Adenylyl Cyclases | 2 | 1997 | 75 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1999 | 105 | 0.040 |
Why?
|
| Nucleic Acid Hybridization | 3 | 1989 | 396 | 0.040 |
Why?
|
| Blastocyst | 1 | 1999 | 76 | 0.040 |
Why?
|
| Biotechnology | 2 | 1997 | 55 | 0.040 |
Why?
|
| Intestines | 1 | 2003 | 570 | 0.040 |
Why?
|
| Respiratory System | 1 | 1999 | 95 | 0.040 |
Why?
|
| Homeostasis | 1 | 2003 | 683 | 0.040 |
Why?
|
| Response Elements | 2 | 2010 | 97 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 1996 | 316 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2000 | 752 | 0.040 |
Why?
|
| Anovulation | 1 | 1997 | 4 | 0.040 |
Why?
|
| Uterine Diseases | 1 | 1997 | 33 | 0.040 |
Why?
|
| Activating Transcription Factor 1 | 1 | 1997 | 4 | 0.040 |
Why?
|
| Embryonic Development | 1 | 1999 | 209 | 0.040 |
Why?
|
| Exocrine Glands | 1 | 1997 | 8 | 0.030 |
Why?
|
| Stromal Cells | 1 | 1998 | 294 | 0.030 |
Why?
|
| Pituitary-Adrenal System | 1 | 1997 | 36 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 1999 | 452 | 0.030 |
Why?
|
| Oncogene Proteins | 1 | 1997 | 137 | 0.030 |
Why?
|
| Oviducts | 5 | 1989 | 329 | 0.030 |
Why?
|
| Brain Chemistry | 2 | 1997 | 122 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2015 | 352 | 0.030 |
Why?
|
| Interleukin-1 | 3 | 2002 | 143 | 0.030 |
Why?
|
| Mice, Transgenic | 3 | 2015 | 2394 | 0.030 |
Why?
|
| Receptors, Dopamine D1 | 1 | 1997 | 85 | 0.030 |
Why?
|
| Pituitary Neoplasms | 1 | 1997 | 83 | 0.030 |
Why?
|
| Epitopes | 2 | 1988 | 429 | 0.030 |
Why?
|
| Phosphorylation | 4 | 2009 | 1610 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 1997 | 384 | 0.030 |
Why?
|
| Coronary Vessels | 2 | 2010 | 526 | 0.030 |
Why?
|
| Acid Phosphatase | 1 | 1995 | 11 | 0.030 |
Why?
|
| Glucan 1,4-alpha-Glucosidase | 1 | 1995 | 5 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 1997 | 617 | 0.030 |
Why?
|
| Phytic Acid | 1 | 1995 | 10 | 0.030 |
Why?
|
| Receptors, Dopamine | 2 | 1993 | 40 | 0.030 |
Why?
|
| Dexamethasone | 1 | 1997 | 271 | 0.030 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 1996 | 71 | 0.030 |
Why?
|
| Ubiquitins | 2 | 1992 | 42 | 0.030 |
Why?
|
| Tripartite Motif Proteins | 1 | 2015 | 15 | 0.030 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2015 | 19 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 1995 | 96 | 0.030 |
Why?
|
| Sulfonamides | 1 | 1997 | 259 | 0.030 |
Why?
|
| Gestational Age | 1 | 1999 | 1139 | 0.030 |
Why?
|
| Infertility, Female | 1 | 1996 | 165 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1995 | 426 | 0.030 |
Why?
|
| Receptors, IgE | 1 | 2014 | 10 | 0.030 |
Why?
|
| Cyclin D1 | 2 | 2009 | 111 | 0.030 |
Why?
|
| Tryptases | 1 | 2014 | 20 | 0.030 |
Why?
|
| Anti-Infective Agents | 1 | 1997 | 266 | 0.030 |
Why?
|
| Hyperplasia | 3 | 2001 | 209 | 0.030 |
Why?
|
| Chemokines | 1 | 2014 | 136 | 0.030 |
Why?
|
| Conalbumin | 1 | 1992 | 1 | 0.030 |
Why?
|
| Age Factors | 2 | 1999 | 2799 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2014 | 162 | 0.030 |
Why?
|
| Genomic Library | 1 | 1992 | 39 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1992 | 188 | 0.030 |
Why?
|
| Estrogen Antagonists | 1 | 1993 | 103 | 0.030 |
Why?
|
| Aspergillus nidulans | 1 | 1992 | 23 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2015 | 339 | 0.030 |
Why?
|
| alpha-Amylases | 1 | 1992 | 9 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 260 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 426 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 1992 | 64 | 0.020 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 2 | 2002 | 56 | 0.020 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2003 | 52 | 0.020 |
Why?
|
| Parity | 2 | 2002 | 78 | 0.020 |
Why?
|
| Escherichia coli | 2 | 1995 | 983 | 0.020 |
Why?
|
| Liver | 1 | 1999 | 1736 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 2015 | 416 | 0.020 |
Why?
|
| Gene Library | 1 | 1992 | 220 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 1988 | 1009 | 0.020 |
Why?
|
| Levodopa | 1 | 1992 | 90 | 0.020 |
Why?
|
| RNA Splicing | 1 | 1992 | 224 | 0.020 |
Why?
|
| Carcinogens | 2 | 2002 | 153 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 2 | 2002 | 260 | 0.020 |
Why?
|
| Steroids | 1 | 1992 | 201 | 0.020 |
Why?
|
| Cattle | 1 | 1992 | 557 | 0.020 |
Why?
|
| Dinoprostone | 2 | 2002 | 76 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2010 | 4 | 0.020 |
Why?
|
| Ovalbumin | 1 | 1991 | 318 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 2012 | 294 | 0.020 |
Why?
|
| Molecular Weight | 4 | 1992 | 391 | 0.020 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2010 | 63 | 0.020 |
Why?
|
| Protein Conformation | 2 | 1989 | 833 | 0.020 |
Why?
|
| Brain | 2 | 1999 | 2967 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2010 | 318 | 0.020 |
Why?
|
| E2F Transcription Factors | 1 | 2009 | 24 | 0.020 |
Why?
|
| Cyclin D2 | 1 | 2009 | 14 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1992 | 1584 | 0.020 |
Why?
|
| Swine | 1 | 1992 | 1155 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2010 | 324 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2009 | 77 | 0.020 |
Why?
|
| Tunica Intima | 1 | 2009 | 59 | 0.020 |
Why?
|
| Trans-Activators | 1 | 1992 | 809 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2010 | 614 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2007 | 93 | 0.020 |
Why?
|
| Avidin | 1 | 1987 | 18 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 1994 | 1268 | 0.020 |
Why?
|
| Disease Models, Animal | 3 | 2003 | 4288 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2010 | 514 | 0.020 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 3 | 1993 | 79 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1987 | 85 | 0.020 |
Why?
|
| Helicobacter pylori | 1 | 1996 | 1315 | 0.020 |
Why?
|
| Serotonin | 2 | 1999 | 232 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2006 | 41 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2006 | 49 | 0.020 |
Why?
|
| Myometrium | 1 | 2006 | 48 | 0.020 |
Why?
|
| Mucin-1 | 1 | 2006 | 34 | 0.020 |
Why?
|
| Norepinephrine | 2 | 1999 | 174 | 0.020 |
Why?
|
| Cross Reactions | 1 | 1986 | 192 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2005 | 31 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2001 | 12142 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2005 | 51 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2005 | 29 | 0.020 |
Why?
|
| Species Specificity | 1 | 1986 | 548 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2006 | 206 | 0.020 |
Why?
|
| Aorta | 1 | 2009 | 542 | 0.020 |
Why?
|
| Methamphetamine | 1 | 2005 | 32 | 0.020 |
Why?
|
| Quinpirole | 2 | 1997 | 6 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2006 | 347 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 171 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2006 | 315 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2005 | 151 | 0.010 |
Why?
|
| alpha-Synuclein | 1 | 2005 | 114 | 0.010 |
Why?
|
| Homozygote | 2 | 1996 | 532 | 0.010 |
Why?
|
| Mitochondrial Proteins | 1 | 2005 | 239 | 0.010 |
Why?
|
| Vesicular Biogenic Amine Transport Proteins | 1 | 2003 | 1 | 0.010 |
Why?
|
| Aromatic-L-Amino-Acid Decarboxylases | 1 | 2003 | 17 | 0.010 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2003 | 15 | 0.010 |
Why?
|
| Chimera | 2 | 1995 | 87 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2007 | 714 | 0.010 |
Why?
|
| Injections, Intralesional | 1 | 2002 | 47 | 0.010 |
Why?
|
| Thymidine Kinase | 1 | 2002 | 95 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2002 | 145 | 0.010 |
Why?
|
| Reproductive History | 1 | 2001 | 10 | 0.010 |
Why?
|
| Ganciclovir | 1 | 2002 | 102 | 0.010 |
Why?
|
| Perphenazine | 1 | 2001 | 6 | 0.010 |
Why?
|
| Ergolines | 2 | 1991 | 7 | 0.010 |
Why?
|
| Okadaic Acid | 2 | 1991 | 14 | 0.010 |
Why?
|
| Ethers, Cyclic | 2 | 1991 | 14 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2001 | 60 | 0.010 |
Why?
|
| Hormone Antagonists | 1 | 2001 | 63 | 0.010 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2001 | 98 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2001 | 78 | 0.010 |
Why?
|
| Carotid Artery, Common | 1 | 2001 | 73 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2001 | 458 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2002 | 233 | 0.010 |
Why?
|
| Oxazolone | 1 | 2000 | 1 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 1991 | 162 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2003 | 544 | 0.010 |
Why?
|
| In Vitro Techniques | 2 | 1991 | 966 | 0.010 |
Why?
|
| Precipitin Tests | 2 | 1991 | 151 | 0.010 |
Why?
|
| Choline O-Acetyltransferase | 1 | 1999 | 13 | 0.010 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 1999 | 28 | 0.010 |
Why?
|
| Substantia Nigra | 1 | 1999 | 33 | 0.010 |
Why?
|
| Transplantation Chimera | 1 | 1999 | 39 | 0.010 |
Why?
|
| Dopamine Agents | 1 | 1999 | 28 | 0.010 |
Why?
|
| Knee Joint | 1 | 2001 | 160 | 0.010 |
Why?
|
| Genetic Vectors | 2 | 1997 | 940 | 0.010 |
Why?
|
| Receptors, Interleukin-8A | 1 | 1999 | 9 | 0.010 |
Why?
|
| DNA Replication | 1 | 2001 | 350 | 0.010 |
Why?
|
| Receptors, Interleukin | 1 | 1999 | 32 | 0.010 |
Why?
|
| Cell Count | 1 | 1999 | 250 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 1999 | 62 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 1999 | 115 | 0.010 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2000 | 201 | 0.010 |
Why?
|
| Organ Size | 1 | 1999 | 412 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2001 | 1214 | 0.010 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 1999 | 174 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 1999 | 200 | 0.010 |
Why?
|
| Diethylstilbestrol | 2 | 1989 | 142 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2001 | 861 | 0.010 |
Why?
|
| DNA Mutational Analysis | 2 | 1991 | 790 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 1999 | 209 | 0.010 |
Why?
|
| Reference Values | 1 | 1999 | 697 | 0.010 |
Why?
|
| Allergens | 1 | 2000 | 249 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1997 | 109 | 0.010 |
Why?
|
| Prolactin | 1 | 1997 | 104 | 0.010 |
Why?
|
| Pituitary Gland | 1 | 1997 | 84 | 0.010 |
Why?
|
| Muscarinic Agonists | 1 | 1997 | 6 | 0.010 |
Why?
|
| Carbachol | 1 | 1997 | 18 | 0.010 |
Why?
|
| Isoquinolines | 1 | 1997 | 40 | 0.010 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1997 | 88 | 0.010 |
Why?
|
| Receptors, Dopamine D2 | 1 | 1997 | 45 | 0.010 |
Why?
|
| Antigens, CD | 1 | 1999 | 420 | 0.010 |
Why?
|
| Skin | 1 | 2000 | 505 | 0.010 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1997 | 188 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2002 | 743 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1996 | 180 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1997 | 160 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 1999 | 518 | 0.010 |
Why?
|
| Endometritis | 1 | 1996 | 9 | 0.010 |
Why?
|
| Neuroimmunomodulation | 1 | 1996 | 15 | 0.010 |
Why?
|
| Copulation | 1 | 1995 | 10 | 0.010 |
Why?
|
| Growth Substances | 1 | 1995 | 113 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2001 | 1679 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1997 | 527 | 0.010 |
Why?
|
| Decidua | 1 | 1995 | 136 | 0.010 |
Why?
|
| Incidence | 1 | 2002 | 3045 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2001 | 993 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1997 | 570 | 0.010 |
Why?
|
| Feedback | 1 | 1995 | 162 | 0.010 |
Why?
|
| Bone and Bones | 1 | 1996 | 262 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 1995 | 312 | 0.010 |
Why?
|
| Polyunsaturated Alkamides | 1 | 1993 | 22 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 6221 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1994 | 462 | 0.010 |
Why?
|
| Potassium Chloride | 1 | 1992 | 54 | 0.010 |
Why?
|
| Pheochromocytoma | 1 | 1992 | 33 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1996 | 1681 | 0.010 |
Why?
|
| Nerve Growth Factors | 1 | 1992 | 72 | 0.010 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1992 | 63 | 0.010 |
Why?
|
| Coturnix | 1 | 1991 | 5 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 1997 | 520 | 0.010 |
Why?
|
| 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 1 | 1991 | 39 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1991 | 105 | 0.010 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1991 | 24 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 1993 | 399 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1993 | 809 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1993 | 356 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 1999 | 1697 | 0.010 |
Why?
|
| Epinephrine | 1 | 1991 | 175 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1992 | 459 | 0.010 |
Why?
|
| Solubility | 1 | 1990 | 132 | 0.010 |
Why?
|
| Action Potentials | 1 | 1992 | 501 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1989 | 97 | 0.010 |
Why?
|
| Reticulocytes | 1 | 1989 | 42 | 0.000 |
Why?
|
| Cosmids | 1 | 1987 | 48 | 0.000 |
Why?
|
| RNA Caps | 1 | 1987 | 31 | 0.000 |
Why?
|
| Rabbits | 1 | 1989 | 709 | 0.000 |
Why?
|
| Cell Line, Transformed | 1 | 1987 | 170 | 0.000 |
Why?
|
| Risk Factors | 1 | 2001 | 10031 | 0.000 |
Why?
|
| Metaphase | 1 | 1987 | 44 | 0.000 |
Why?
|
| Hybrid Cells | 1 | 1987 | 80 | 0.000 |
Why?
|
| DNA, Recombinant | 1 | 1987 | 100 | 0.000 |
Why?
|
| Cricetulus | 1 | 1987 | 97 | 0.000 |
Why?
|
| Immunoblotting | 1 | 1987 | 312 | 0.000 |
Why?
|
| Oncogene Proteins v-erbA | 1 | 1987 | 7 | 0.000 |
Why?
|
| Retroviridae Proteins | 1 | 1987 | 13 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1986 | 120 | 0.000 |
Why?
|
| Trypsin | 1 | 1986 | 95 | 0.000 |
Why?
|
| Cricetinae | 1 | 1987 | 410 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1986 | 747 | 0.000 |
Why?
|